Chemotherapy in reticulum-cell sarcoma in five dogs and a cat and in mast-cell leukemia in a cat.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D003520:Cyclophosphamide / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005153:Facial Neoplasms / Q000188:drug therapy / Q000662:veterinary; D005260:Female; D007938:Leukemia / Q000188:drug therapy / Q000662:veterinary*; D008206:Lymphatic Diseases / Q000188:drug therapy / Q000662:veterinary; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000662:veterinary*; D008297:Male; D008407:Mast Cells; D008775:Methylprednisolone / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000662:veterinary; D012878:Skin Neoplasms / Q000188:drug therapy / Q000662:veterinary*
D000970:Antineoplastic Agents; D001389:Azirines; D002219:Carbamates; D003520:Cyclophosphamide; D008775:Methylprednisolone